Christchurch retirement village operator Ryman Healthcare has reported a sharply smaller annual loss for the year to March 2026, with chief executive Naomi James saying the company’s two-year operating reset is delivering materially improved financial performance.
The NZX-listed group posted a net loss after tax of 171 million dollars, down from a 513 million dollar loss the previous year and the smallest annual deficit since the housing market downturn began to weigh on retirement village resales.
Operating revenue rose around 10 percent to 855 million dollars, while underlying earnings before interest, tax, depreciation, amortisation and fair value movements lifted 94 percent to 88 million dollars. Free cash flow turned positive for the first time in more than a decade, landing at 188 million dollars.
In its market release, Ryman said the result reflected a deliberate shift away from the rapid expansion that had carried the company through the previous decade. Development capital expenditure of 159.5 million dollars came in below guidance, and the board has scaled back its planned retirement living build rate to between 157 and 168 units in FY27, less than half the 330 units delivered in FY26.
Gearing fell to 27.8 percent, which the company said was the lowest in the listed retirement sector. Ryman has fully refinanced its bank facilities and now has no bank maturities until the 2031 financial year, the result of last year’s 1 billion dollar equity raise and a series of land sales that have lifted the divestment target from 200 million dollars to around 250 million dollars. The company said 147 million dollars of those sales had already been settled or contracted, including the 30.9 million Australian dollar sale of its Kealba site in Melbourne.
Naomi James said the figures showed the new strategy was working. “The reset of our operating model is delivering materially improved financial performance despite mixed market conditions and creating a more sustainable business,” she told RNZ.
The company is now framing the next stage of its recovery as an earnings story rather than a balance sheet story. Aged care contributed underlying earnings of about 17,700 dollars per bed in FY26, and Ryman has set itself a target of between 20,000 and 25,000 dollars per bed in FY27. Management has also flagged a return to sustainable dividends in FY28, subject to operating performance and board approval. No dividend will be paid for the year just reported.
Ryman runs more than 40 villages across New Zealand and Australia and employs more than 7,000 staff. The company has been one of the worst-performing large NZX stocks over the past three years as a sluggish housing market dragged on resales of occupation rights, which had been a key source of cash flow under the older expansion-led model. The strategy under Naomi James has prioritised selling down completed inventory before committing to new builds.
Industry publication The Weekly Source reported that Ryman has now achieved 47 million dollars of a 150 million dollar sustainable cash flow improvement target that management has committed to deliver by the 2029 financial year. The target is the central measure investors are using to judge whether the recovery is on track.
The result lands at a delicate moment for the wider retirement village sector. Smaller operators have been forced to close homes, and Grant Thornton has floated the idea of residents paying bonds as high as 650,000 dollars to enter aged care under one funding proposal currently being considered by the Government. Ryman’s scale and refreshed balance sheet position it differently to mid-sized operators that are still struggling to refinance in the current rate environment.
Australian sharemarket commentary site Stocks Down Under noted that Ryman’s shift to selling existing capacity rather than chasing new builds marked a clear break from the company’s historical strategy, and that the FY26 number suggested the operating reset had begun to translate into real cash generation rather than just balance sheet repair.
Looking ahead, Ryman said its FY27 priorities would be growing aged care earnings, releasing cash from completed retirement living inventory, and continuing to wind down capital spending. The company is targeting a step-change in aged care profitability by lifting occupancy and adjusting fees, and is now selling existing capacity rather than committing to new villages.
Investors and analysts will be watching the next interim result, due in November, for evidence that the rebound in cash flow can be repeated across a full year. Ryman’s recovery is one of the biggest tests of operational management on the NZX, and on the FY26 numbers the early signs are that the reset is delivering.
Do you think Ryman’s turnaround is genuine, or do you see another year of soft house prices keeping a lid on resale margins, and what does the wider retirement village sector need to look like in five years time? Please share your view in the comments below.
This article was written by AI, briefed to report the facts, hopefully without some of the bias people bring to the job 🙂
Leave a Reply